American Journal of Ophthalmology
Volume 143, Issue 4 , Pages 566-583.e2, April 2007

An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration

  • Anne E. Fung

      Affiliations

    • Pacific Eye Associates, California Pacific Medical Center, San Francisco, California
    • ,
  • Geeta A. Lalwani

      Affiliations

    • Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
    • ,
  • Philip J. Rosenfeld

      Affiliations

    • Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
    • Corresponding Author InformationInquiries to Philip J. Rosenfeld, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 N.W. 17th Street, Miami, FL 33136;
    • ,
  • Sander R. Dubovy

      Affiliations

    • Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
    • ,
  • Stephan Michels

      Affiliations

    • University Eye Hospital Vienna, Austria.
    • ,
  • William J. Feuer

      Affiliations

    • Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
    • ,
  • Carmen A. Puliafito

      Affiliations

    • Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
    • ,
  • Janet L. Davis

      Affiliations

    • Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
    • ,
  • Harry W. Flynn Jr

      Affiliations

    • Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
    • ,
  • Maria Esquiabro

      Affiliations

    • Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida

Accepted 13 January 2007. published online 15 February 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 See accompanying Editorial on page 679.

PII: S0002-9394(07)00068-2

doi:10.1016/j.ajo.2007.01.028

Refers to article:

  • Ranibizumab According to Need: A Treatment for Age-related Macular Degeneration

    Richard Spaide
    American Journal of Ophthalmology April 2007 (Vol. 143, Issue 4, Pages 679-680)

American Journal of Ophthalmology
Volume 143, Issue 4 , Pages 566-583.e2, April 2007

Article Tools

* Image Usage & Resolution